内部人士在外科合作伙伴报告低于预期的收益和负率后,卖出了超过17,000股. Insiders sold over 17,000 shares after Surgery Partners reported below-expected earnings and a negative P/E ratio.

根据该公司第四季度财报,包括丹尼尔·伯克哈特 (Danielle Burkhalter),玛丽莎·布里顿汉姆 (Marissa Brittenham) 和詹妮弗·巴尔多克 (Jennifer Baldock) 在内的外科合作伙伴在2026年3月中旬总共出售了超过17,000股股票,每股收益为0.12美元,低于预期,收入增长2.4%. Surgery Partners insiders, including Danielle Burkhalter, Marissa Brittenham, and Jennifer Baldock, sold a combined total of over 17,000 shares in mid-March 2026, following the company’s Q4 earnings report showing $0.12 EPS, below estimates, and a 2.4% revenue increase. 股票收盘价为12.39美元,市值16亿美元和负率. The stock closed at $12.39, with a market cap of $1.6 billion and a negative P/E ratio. 尽管内部人士的销售,分析师保持"中等买入"评级以23.36美元为目标. Despite the insider sales, analysts maintain a “Moderate Buy” rating with a $23.36 target. 京东增加了1.225万股的股份. King Street Capital increased its stake by 1.225 million shares.